Cabaletta Bio (CABA)
2.98
-0.14 (4.49%)
Upcoming Events
Latest Headlines
Increasing unusual call option volume: GDS AM PGEN DFTX CTSH SWKS AIG BFLY OTLK EH CABA
June 23, 2026 3:36 AM - StreetInsider
Form 8-K Cabaletta Bio, Inc. For: Jun 09
June 11, 2026 7:01 AM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: Tomasello Shawn
June 10, 2026 7:04 PM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: Simon Mark
June 10, 2026 7:00 PM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: HENRIQUES RICHARD C JR
June 10, 2026 6:56 PM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: Bollard Catherine
June 10, 2026 6:54 PM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: Brun Scott C.
June 10, 2026 6:51 PM - SEC Filing
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: PRUDENTIAL FINANCIAL INC
June 5, 2026 2:10 PM - SEC Filing
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: JENNISON ASSOCIATES LLC
June 4, 2026 4:18 PM - SEC Filing
Jefferies on Cabaletta Bio (CABA): 'We came away from EULAR 2026 update increasingly positive on the wholistic resecel profile'
June 3, 2026 7:31 AM - StreetInsider
Cabaletta Bio reports positive rese-cel data in autoimmune diseases
June 3, 2026 7:03 AM - StreetInsider
Form 8-K Cabaletta Bio, Inc. For: Jun 03
June 3, 2026 7:02 AM - SEC Filing
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
June 3, 2026 7:00 AM - StreetInsider
Form DEFA14A Cabaletta Bio, Inc.
June 1, 2026 7:30 AM - SEC Filing
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Cormorant Asset Management, LP
May 15, 2026 1:21 PM - SEC Filing
Cabaletta Bio (CABA) PT Raised to $4 at Wells Fargo
May 15, 2026 6:28 AM - StreetInsider
Cabaletta Bio, Inc. (CABA) Reports In-Line Q1 EPS
May 14, 2026 7:35 AM - StreetInsider
Form 10-Q Cabaletta Bio, Inc. For: Mar 31
May 14, 2026 7:09 AM - SEC Filing
Form 8-K Cabaletta Bio, Inc. For: May 14
May 14, 2026 7:07 AM - SEC Filing
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026 7:05 AM - Globe NewsWire
Form 8-K Cabaletta Bio, Inc. For: May 14
May 14, 2026 7:03 AM - SEC Filing
Cabaletta Bio reports clinical data for preconditioning-free rese-cel
May 14, 2026 7:01 AM - StreetInsider
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
May 14, 2026 7:01 AM - Globe NewsWire
Guggenheim on Cabaletta Bio (CABA): 'compelling evidence that CAR-T activity can be achieved without preconditioning'
May 4, 2026 9:20 AM - StreetInsider
Form 8-K Cabaletta Bio, Inc. For: May 04
May 4, 2026 6:41 AM - SEC Filing
Form 424B5 Cabaletta Bio, Inc.
May 4, 2026 6:38 AM - SEC Filing
Cabaletta Bio prices $150 million stock offering at $2.90 per share
May 4, 2026 6:37 AM - StreetInsider
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
May 4, 2026 6:35 AM - Globe NewsWire
Form 8-K Cabaletta Bio, Inc. For: May 04
May 4, 2026 6:06 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Cabaletta Bio Inc. (CABA)
April 29, 2026 7:25 AM - StreetInsider
Cabaletta Bio signs 10-year manufacturing deal with Cellares for rese-cel
April 28, 2026 8:01 AM - StreetInsider
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
April 28, 2026 8:00 AM - Globe NewsWire
Cellares and Cabaletta Bio sign 10-year manufacturing deal for rese-cel
April 28, 2026 8:00 AM - StreetInsider
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel
April 28, 2026 8:00 AM - BizWire
Form ARS Cabaletta Bio, Inc. For: Dec 31
April 28, 2026 7:42 AM - SEC Filing
Form DEFA14A Cabaletta Bio, Inc.
April 28, 2026 7:35 AM - SEC Filing
Form DEF 14A Cabaletta Bio, Inc. For: Jun 09
April 28, 2026 7:31 AM - SEC Filing
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
April 27, 2026 5:00 PM - StreetInsider
Form 8-K Cabaletta Bio, Inc. For: Apr 20
April 20, 2026 7:02 AM - SEC Filing
Form PRE 14A Cabaletta Bio, Inc. For: Jun 09
April 17, 2026 7:45 AM - SEC Filing
First Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform
April 14, 2026 4:30 PM - BizWire
Full Article List
